Literature DB >> 12419226

CSB is a component of RNA pol I transcription.

John Bradsher1, Jerome Auriol, Luca Proietti de Santis, Sebastian Iben, Jean Luc Vonesch, Ingrid Grummt, Jean Marc Egly.   

Abstract

Mutation in the CSB gene results in the human Cockayne's syndrome (CS). Here, we provide evidence that CSB is found not only in the nucleoplasm but also in the nucleolus within a complex (CSB IP/150) that contains RNA pol I, TFIIH, and XPG and promotes efficient rRNA synthesis. CSB is active in in vitro RNA pol I transcription and restores rRNA synthesis when transfected in CSB-deficient cells. We also show that mutations in CSB, as well as in XPB and XPD genes, all of which confer CS, disturb the RNA pol I/TFIIH interaction within the CSB IP/150. In addition to revealing an unanticipated function for CSB in rRNA synthesis, we show that the fragility of this complex could be one factor contributing to the CS phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419226     DOI: 10.1016/s1097-2765(02)00678-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  98 in total

Review 1.  Cockayne syndrome group B cellular and biochemical functions.

Authors:  Cecilie Löe Licht; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

2.  Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition.

Authors:  Jingsheng Tuo; Baitang Ning; Christine M Bojanowski; Zhong-Ning Lin; Robert J Ross; George F Reed; Defen Shen; Xiaodong Jiao; Min Zhou; Emily Y Chew; Fred F Kadlubar; Chi-Chao Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

3.  CTD kinase I is involved in RNA polymerase I transcription.

Authors:  Céline Bouchoux; Guillaume Hautbergue; Sabrina Grenetier; Christophe Carles; Michel Riva; Valérie Goguel
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

4.  Initiation of DNA repair mediated by a stalled RNA polymerase IIO.

Authors:  Jean-Philippe Lainé; Jean-Marc Egly
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

5.  CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome.

Authors:  Regina Groisman; Isao Kuraoka; Odile Chevallier; Nogaye Gaye; Thierry Magnaldo; Kiyoji Tanaka; Alexei F Kisselev; Annick Harel-Bellan; Yoshihiro Nakatani
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

Review 6.  Nucleotide excision repair in humans.

Authors:  Graciela Spivak
Journal:  DNA Repair (Amst)       Date:  2015-09-10

7.  Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome.

Authors:  Katsuyoshi Horibata; Yuka Iwamoto; Isao Kuraoka; Nicolaas G J Jaspers; Akihiro Kurimasa; Mitsuo Oshimura; Masamitsu Ichihashi; Kiyoji Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

8.  Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method.

Authors:  Naoko Shiomi; Seiji Kito; Masaki Oyama; Tsukasa Matsunaga; Yoshi-Nobu Harada; Masahito Ikawa; Masaru Okabe; Tadahiro Shiomi
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress.

Authors:  Tina Thorslund; Cayetano von Kobbe; Jeanine A Harrigan; Fred E Indig; Mette Christiansen; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 10.  Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance.

Authors:  Maria D Aamann; Meltem Muftuoglu; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Mech Ageing Dev       Date:  2013-04-09       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.